Skip to Content

Clinical Cancer Genetics Program

Karen Lu, M.D.

Co-Medical Director
Gynecologic Oncology

Banu Arun, M.D.
Co-Medical Director
Breast Medical Oncology

Approximately 5-10% of cancer is inherited. Individuals with a genetic predisposition will have a far higher chance of developing cancer within their lifetime and at an earlier age. Genetic testing can help determine whether a family has a hereditary cancer predisposition syndrome. Individuals who have genetically higher risks to develop certain cancers are recommended to follow high-risk cancer surveillance and management. The Clinical Cancer Genetics Program can coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes.  For further information please view our 


Referral Guidelines:     Breast Center    Endocrine Center    GI Center    Gynecologic Oncology Center    Pediatrics and Rare Diseases   

Familial Adenomatous Polyposis (FAP) 
Patient Education Conference
Saturday, May 10, 2014
8:30 am – 2:15 pm
Cancer Prevention Building, 8th Floor, 
1155 Pressler Street

* Registration is FREE begins at 8:00 am.

The Clinical Cancer Genetics Program presents an opportunity for patients to learn about the latest developments in clinical care and research focusing on this hereditary syndrome.

Agenda Items Include:

  • Overview of FAP
  • Importance of knowing your family health history
  • Updates on genetic testing
  • Surveillance of the GI Tract
  • Round-table discussions with MD Anderson experts

To Register call 713-745-7391
Please Register by May 3rd.

Free Parking:
Pressler garage Pressler Dr between Fannin & Bertner)
Use the skybridge on the 4th floor of garage and follow signs to the Cancer Prevention Building

Conference Brochure (pdf)

CCG Annual Report

© 2014 The University of Texas MD Anderson Cancer Center